XML 85 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
Earnings per Share
6 Months Ended
Jun. 30, 2015
Earnings Per Share [Abstract]  
Earnings per Share
Earnings per Share
The Company has unvested shares of restricted stock and restricted stock units outstanding that are considered participating securities and, therefore, computes basic and diluted earnings per share under the two-class method. Basic earnings per share for the periods are based upon the weighted average number of shares of common stock outstanding during the periods. Diluted earnings per share include the effect of certain stock options.
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2015
 
2014
 
2015
 
2014
Net income attributable to
   Westlake Chemical Corporation
 
$
205,095

 
$
169,443

 
$
351,437

 
$
327,475

Less:
 
 
 
 
 
 
 
 
Net income attributable to participating securities
 
(253
)
 
(360
)
 
(457
)
 
(746
)
Net income attributable to common shareholders
 
$
204,842

 
$
169,083

 
$
350,980

 
$
326,729


The following table reconciles the denominator for the basic and diluted earnings per share computations shown in the consolidated statements of operations:
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
 
2015
 
2014
 
2015
 
2014
Weighted average common shares—basic
 
132,538,123

 
133,223,705

 
132,625,857

 
133,148,398

Plus incremental shares from:
 
 
 
 
 
 
 
 
Assumed exercise of options
 
506,852

 
544,185

 
498,840

 
542,438

Weighted average common shares—diluted
 
133,044,975

 
133,767,890

 
133,124,697

 
133,690,836

 
 
 
 
 
 
 
 
 
Earnings per common share attributable to
   Westlake Chemical Corporation:
 
 
 
 
 
 
 
 
Basic
 
$
1.55

 
$
1.27

 
$
2.65

 
$
2.45

Diluted
 
$
1.54

 
$
1.26

 
$
2.64

 
$
2.44


Excluded from the computation of diluted earnings per share are options to purchase 330,315 and 134,938 shares of common stock for the three months ended June 30, 2015 and 2014, respectively, and 285,933 and 102,480 shares of common stock for the six months ended June 30, 2015 and 2014, respectively. These options were outstanding during the periods reported but were excluded because the effect of including them would have been antidilutive.